Cited by 1,154Tuberculosis Research and EpidemiologyInfectious Diseases and TuberculosisMycobacterium research and diagnosis

The DOI matches its Crossref record; 322 of the 322 references it cites were found in a registry or an index.

Mycobacterium tuberculosis Pathogenesis and Molecular Determinants of Virulence

Open access

Smith, Issar·2003·Clinical Microbiology Reviews

DOI 10.1128/cmr.16.3.463-496.2003PMC PMC164219

Open this paper in CoChat — free account

Abstract

Tuberculosis (TB), one of the oldest known human diseases. is still is one of the major causes of mortality, since two million people die each year from this malady. TB has many manifestations, affecting bone, the central nervous system, and many other organ systems, but it is primarily a pulmonary disease that is initiated by the deposition of Mycobacterium tuberculosis, contained in aerosol droplets, onto lung alveolar surfaces. From this point, the progression of the disease can have several outcomes, determined largely by the response of the host immune system. The efficacy of this response is affected by intrinsic factors such as the genetics of the immune system as well as extrinsic factors, e.g., insults to the immune system and the nutritional and physiological state of the host. In addition, the pathogen may play a role in disease progression since some M. tuberculosis strains are reportedly more virulent than others, as defined by increased transmissibility as well as being associated with higher morbidity and mortality in infected individuals. Despite the widespread use of an attenuated live vaccine and several antibiotics, there is more TB than ever before, requiring new vaccines and drugs and more specific and rapid diagnostics. Researchers are utilizing information obtained from the complete sequence of the M. tuberculosis genome and from new genetic and physiological methods to identify targets in M. tuberculosis that will aid in the development of these sorely needed antitubercular agents.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1128/cmr.16.3.463-496.2003

Cites

322 of 322 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence
Cole, S. T., Brosch, R., Parkhill, J., Garnier, T., Churcher, C., Harris, D., Gordon, S. V., Eiglmeier, K., Gas, S., Barry, C. E., et al. (1998) · Nature · doi:10.1038/31159 · Cited by 7,847
Molecular Beacons: Probes that Fluoresce upon Hybridization
Tyagi, S., & Kramer, F. R. (1996) · Nature Biotechnology · doi:10.1038/nbt0396-303 · Cited by 4,164
Complete genome sequence of the model actinomycete Streptomyces coelicolor A3(2)
Bentley, S. D., Chater, K. F., Cerdeño-Tárraga, A. M., Challis, G. L., Thomson, N. R., James, K., Harris, D. E., Quail, M. A., Kieser, H. M., Harper, D., et al. (2002) · Nature · doi:10.1038/417141a · Cited by 3,226
Functional Discovery via a Compendium of Expression Profiles
Hughes, T. R., Marton, M. J., Jones, A. R., Roberts, C. J., Stoughton, R. B., Armour, C. D., Bennett, H. A., Coffey, E. M., Dai, H. A., He, Y. D., et al. (2000) · Cell · doi:10.1016/s0092-8674(00)00015-5 · Cited by 2,534
Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines
Hoiseth, S. K., & Stocker, B. A. D. (1981) · Nature · doi:10.1038/291238a0 · Cited by 2,088
THE ENVELOPE OF MYCOBACTERIA
Brennan, P. J., & Nikaido, H. (1995) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.64.070195.000333 · Cited by 2,045
Massive gene decay in the leprosy bacillus.
Cole, S. T., Eiglmeier, K., Parkhill, J., James, K. D., Thomson, N. R., Wheeler, P. R., Honoré, N., Garnier, T., Churcher, C., Harris, D., et al. (2001) · Nature · doi:10.1038/35059006 · Cited by 1,777
Host Defense Mechanisms Triggered by Microbial Lipoproteins Through Toll-Like Receptors
Brightbill, H. D., Libraty, D. H., Krutzik, S. R., Yang, R., Belisle, J. T., Bleharski, J. R., Maitland, M. L., Norgard, M. V., Plevy, S. E., Smale, S. T., et al. (1999) · Science · doi:10.1126/science.285.5428.732 · Cited by 1,659
A new evolutionary scenario for the Mycobacterium tuberculosis complex
Brosch, R., Gordon, S. V., Marmiesse, M., Brodin, P. M., Buchrieser, C., Eiglmeier, K., Garnier, T., Gutierrez, C., Hewinson, R. G., Kremer, K., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.052548299 · Cited by 1,645
Comparative Genomics of BCG Vaccines by Whole-Genome DNA Microarray
Behr, M. A., Wilson, M. A., Gill, W., Salamon, H., Schoolnik, G. K., Rane, S., & Small, P. M. (1999) · Science · doi:10.1126/science.284.5419.1520 · Cited by 1,527

Show all 322 references

Research works printed but not linked: 14

Butcher P. D. J. A. Mangan and I. M. Monahan. 1998. Intracellular gene expression p. 285-306. In T. Parish and N. G. Stoker (ed.) Mycobacterium tuberculosis protocols. Humana Press Totowa N.J.
Derbyshire, K. M., C. Takacs, and J. Huang. 2000. Using the EZ:TNTMTransposomeTM for transposon mutagenesis in Mycobacterium smegmatis.Epicentre Forum7:1-4.
Friedman L. N. (ed.). 2001. Tuberculosis: current concepts and treatment 2nd ed. CRC Press Inc. Boca Raton Fla.
Garay. S. 1996. Pulmonary tuberculosis. p. 373-412. In W. N. Rom and S. Garay (ed.) Tuberculosis. Little Brown and Co. Boston Mass.
Gomez M. and I. Smith. 2000. Determinants of mycobacterial gene expression p. 111-129. In G. F. Hatfull and W. R. Jacobs Jr (ed.) Molcular genetics of mycobacteria. American Society for Microbiology Washington. D.C.
Haas F. and S. S. Haas. 1996. The origins of Mycobacterium tuberculosis and the notion of its contagiousness p. 3-19. In W. N. Rom and S. Garay (ed.) Tuberculosis. Little Brown and Co. Boston Mass.
Hatfull G. F. and W. R. Jacobs Jr. (ed.). 2000. Molecular genetics of mycobacteria. American Society for Microbiology Washington D.C.
Jagirdar J. and D. ZagZag. 1996. Pathology and insights into pathogenesis of tuberculosis p. 467-491. In W. N. Rom and S. Garay (ed.) Tuberculosis. Little Brown and Co. Boston Mass.
Kamholz S. L. 1996. Pleural tuberculosis p. 483-491. In W. N. Rom and S. Garay (ed.) Tuberculosis. Little Brown and Co. Boston Mass.
Munger J. S. and J. H. A. Chapman. 1996. Tissue destruction by proteases p. 353-361. In W. N. Rom and S. Garay (ed.) Tuberculosis. Little Brown and Co. Boston Mass.
Rom W. N. and S. Garay (ed.). 1996. Tuberculosis. Little Brown and Co. Boston Mass.
Talavera W. R. Miranda K. Lessnau and L. Klapholz. 2001. Extrapulmonary tuberculosis p. 139-190. In L. N. Friedman (ed.) Tuberculosis: current concepts and treatment 2nd ed. CRC Press Inc. Boca Raton Fla.
Tyagi A. K. S. K. D. Gupta and S. Jain. 2000. Gene expression: reporter technologies p. 131-147. In G. F. Hatfull and W. R. Jacobs Jr. (ed.) Molecular genetics of mycobacteria. American Society for Microbiology Washington D.C.
Zugar A. and F. D. Lowy. 1996. Tuberculosis of the brain meninges and the spinal cord p. 541-556. In W. N. Rom and S. Gary (ed.) Tuberculosis. Little Brown and Co. Boston Mass.

Sorted by citations

Items 601–700 of 1,000

Metabolic bifunctionality of Rv0812 couples folate and peptidoglycan biosynthesis in Mycobacterium tuberculosis
Black, K. A., Duan, L., Mandyoli, L., Selbach, B. P., Xu, W., Ehrt, S., Sacchettini, J. C., & Rhee, K. Y. (2021) · The Journal of Experimental Medicine · doi:10.1084/jem.20191957 · Cited by 8
Microbial Pathogenesis: Mechanism and Recent Updates on Microbial Diversity of Pathogens
Dhagat, S., & Eswari, S. (2022) · Springer eBooks · doi:10.1007/978-981-16-3120-7_3 · Cited by 8
Green and efficient three-component synthesis of novel isoniazid pyrazoles, molecular docking, antioxidant and antitubercular evaluation
Koli, B. P., Gore, R. P., & Malasane, P. R. (2023) · Synthetic Communications · doi:10.1080/00397911.2023.2235624 · Cited by 8
Protective capacity of proteoliposomes from Mycobacterium bovis BCG in a mouse model of tuberculosis
Tirado, Y., Puig, A., Álvarez, N., Borrero, R., Aguilar, A., Camacho, F., Reyes, F., Fernández-Castillo, S., Pérez, J. L., Mata‐Espinosa, D., et al. (2015) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2015.1011566 · Cited by 8
Bacteriological characterization of a Mycobacterium parascrofulaceum strain isolated from a Chinese pneumonia patient
Liu, G., Wang, G., Yu, X., Liang, Q., Mu, J., Shang, Y., Ling, Y., Zhang, H., Zheng, S., & Huang, H. (2014) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2014.01.023 · Cited by 8
Lipid Nanoparticle Formulations for Enhanced Antituberculosis Therapy
Banerjee, S., & Pillai, J. D. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-47347-7.00011-2 · Cited by 8
Bacteriophage gene products as potential antimicrobials against tuberculosis
Puiu, M., & Julius, C. (2019) · Biochemical Society Transactions · doi:10.1042/bst20180506 · Cited by 8
Infectious Lung Diseases and Endogenous Oxidative Stress
Sarkar, K., & Sil, P. C. (2019) · Springer eBooks · doi:10.1007/978-981-13-8413-4_7 · Cited by 8
Spinal Tuberculosis
Onuminya, J. E., Morgan, E., & Shobode, M. A. (2019) · Nigerian Journal of Orthopaedics and Trauma · doi:10.4103/njot.njot_25_19 · Cited by 8
Preclinical Efficacy of a Trivalent Human FcγRI-Targeted Adjuvant-Free Subunit Mucosal Vaccine against Pulmonary Pneumococcal Infection
Kumar, S., Sunagar, R., & Gosselin, E. J. (2020) · Vaccines · doi:10.3390/vaccines8020193 · Cited by 8
Synthesis and Molecular Docking Study of Pyrazine-2-carboxylic acid Derivatives
Zulqurnain, M., Fahmi, M. R. G., Fadlan, A., & Santoso, M. (2020) · IOP Conference Series Materials Science and Engineering · doi:10.1088/1757-899x/833/1/012057 · Cited by 8
Measurable Genomic Changes in Mycobacterium avium subsp. hominissuis after Long-Term Adaptation in Acanthamoeba lenticulata and Reduced Persistence in Macrophages
Hasan, N. A., Norton, G. J., Virdi, R., Epperson, L. E., Vang, C. K., Hellbusch, B., Bai, X., Chan, E. D., Strong, M., & Honda, J. R. (2021) · Journal of Bacteriology · doi:10.1128/jb.00257-20 · Cited by 8
Lipoprotein capture ELISA method for the sensitive detection of amphiphilic biomarkers
Lenz, K. D., Klosterman, K. E., Mukundan, H., & Kubicek-Sutherland, J. Z. (2022) · Analytical Biochemistry · doi:10.1016/j.ab.2022.114747 · Cited by 8
In silico based virtual screening and mixed mode QM/MM calculation identifies caffeine scaffold for designing potential inhibitors for tyrosyl tRNA synthetase of M ycobacterium tuberculosis
Sathya, R., & Thamotharan, S. (2014) · International Journal of Quantum Chemistry · doi:10.1002/qua.24814 · Cited by 8
Mycobacterium tuberculosis – The Organism
Grange, J. M. (2014) · CRC Press eBooks · doi:10.1201/b16604-3 · Cited by 8
Morphology-based classification of mycobacteria-infected macrophages with convolutional neural network: reveal EsxA-induced morphologic changes indistinguishable by naked eyes
Bao, Y., Zhao, X., Wang, L., Qian, W. P., & Sun, J. (2019) · Translational research · doi:10.1016/j.trsl.2019.06.001 · Cited by 8
Multi-functionalized nanocarriers targeting bacterial reservoirs to overcome challenges of multi drug-resistance
Kiani, M. H., Imran, M., Raza, A., & Shahnaz, G. (2020) · DARU Journal of Pharmaceutical Sciences · doi:10.1007/s40199-020-00337-w · Cited by 8
The Hydrophobic Domain of the Mycobacterial Erp Protein Is Not Essential for the Virulence of Mycobacterium tuberculosis
Kocíncová, D., Sondén, B., Bordat, Y., Pivert, E., Mendonça-Lima, L., Gicquel, B., & Reyrat, J. (2004) · Infection and Immunity · doi:10.1128/iai.72.4.2379-2382.2004 · Cited by 8
Magnitude of tuberculosis lymphadenitis, risk factors, and rifampicin resistance at Adama city, Ethiopia: a cross-sectional study
Kumbi, H., Reda, D. Y., Solomon, M., Teklehaimanot, A., Ormago, M. D., & Ali, M. M. (2023) · Scientific Reports · doi:10.1038/s41598-023-43206-7 · Cited by 7
Development of inhaled moxifloxacin-metformin formulation as an alternative for pulmonary tuberculosis treatment
Simon, A., Velloso-Junior, S. O., Mesquita, R. D., Fontão, A. P. G. A., Costa, T. E. M. M., Honório, T. D. S., Guimarães, T. F., de Sousa, E. G. R., Viçosa, A. L., Sampaio, A. L. F., et al. (2024) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2024.124740 · Cited by 7
Prevalence and predictors of depression in tuberculosis patients in india: a systematic review and meta-analysis
Samal, J., Dehury, R. K., Thomas, M. B., & Singh, H. (2025) · Discover Mental Health · doi:10.1007/s44192-025-00248-9 · Cited by 8
Pleural Tuberculosis: A Febrile Presentation Without Respiratory Symptoms
Ghumman, U., Ghumman, H., Nawab, K., Singh, A., & Naeem, A. (2020) · Cureus · doi:10.7759/cureus.10643 · Cited by 7
M. tuberculosis curli pili (MTP) is associated with alterations in carbon, fatty acid and amino acid metabolism in a THP-1 macrophage infection model
Ashokcoomar, S., Loots, D. T., Beukes, D., van Reenen, M., Pillay, B., & Pillay, M. (2021) · Microbial Pathogenesis · doi:10.1016/j.micpath.2021.104806 · Cited by 7
Towards comprehensive understanding of bacterial genetic diversity: large-scale amplifications in Bordetella pertussis and Mycobacterium tuberculosis
Abrahams, J. S., Weigand, M. R., Ring, N., MacArthur, I., Etty, J., Peng, S., Williams, M. M., Bready, B., Catalano, A. P., Davis, J. R., et al. (2022) · Microbial Genomics · doi:10.1099/mgen.0.000761 · Cited by 10
Single‐cell sequencing: Current applications in various tuberculosis specimen types
Zeng, Y., Ma, Q., Chen, J., Kong, X., Chen, Z., Liu, H., Liu, L., Yan, Q., Wang, X., & Lu, S. (2024) · Cell Proliferation · doi:10.1111/cpr.13698 · Cited by 6
Diagnóstico da tuberculose: uma revisão
Ferri, A. O., Aguiar, B. G., Wilhelm, C. M., Schmidt, D., Fussieger, F., & Picoli, S. U. (2014) · Revista Liberato · doi:10.31514/rliberato.2014v15n24.p145 · Cited by 7
Chromosomal rearrangements and protein globularity changes inMycobacterium tuberculosisisolates from cerebrospinal fluid
Saw, S. H., Tan, J. L., Chan, X.-Y., Chan, K., & Ngeow, Y. F. (2016) · PeerJ · doi:10.7717/peerj.2484 · Cited by 7
Avian Gastric Yeast (Macrorhabdus ornithogaster) and Mycobacterium genavense Infections in a Zoo Budgerigar (Melopsittacus undulatus) Flock
Fulton, R. M., & Mani, R. (2020) · Avian Diseases · doi:10.1637/0005-2086-64.4.561 · Cited by 7
Structural and functional characterization of M. tuberculosis sedoheptulose- 7-phosphate isomerase, a critical enzyme involved in lipopolysaccharide biosynthetic pathway
Karan, S., Pratap, B., Yadav, S. P. S., Ashish, F., & Saxena, A. K. (2020) · Scientific Reports · doi:10.1038/s41598-020-77230-8 · Cited by 7
Immunobiology of tubercle bacilli and prospects of immunomodulatory drugs to tackle tuberculosis (TB) and other non-tubercular mycobacterial infections
Daniel, C., & Bhakta, S. (2022) · Immunobiology · doi:10.1016/j.imbio.2022.152224 · Cited by 7
Seeing is believing: Efficiency evaluation of multifunctional ionic-dependent AIEgens for tuberculosis
Huang, X., Chu, C., Shi, C., Zhang, J., Yan, B., Shan, F., Wang, D., Shi, Y., Peng, C., & Tang, B. Z. (2023) · Biomaterials · doi:10.1016/j.biomaterials.2023.122301 · Cited by 7
Transcriptional analysis of Mycobacterium fortuitum cultures upon hydrogen peroxide treatment using the novel standard rrn A-P1
Núñez, M. C., Menendez, M. C., Rebollo, M. J., & García, M. J. (2008) · BMC Microbiology · doi:10.1186/1471-2180-8-100 · Cited by 7
Is a new tuberculosis vaccine necessary and feasible? A Cuban opinion
Sierra, V. G. (2006) · Tuberculosis · doi:10.1016/j.tube.2006.03.003 · Cited by 7
EXPLORING SOLID LIPID NANOPARTICLES FOR INTRANASAL ADMINISTRATION OF STREPTOMYCIN
Kaur, I. P., & Verma, M. (2011) · International Journal of Pharmacy · Cited by 7
Fullerene quinazolinone conjugates targeting Mycobacterium tuberculosis: a combined molecular docking, QSAR, and ONIOM approach
Mirchi, A., Sizochenko, N., & Leszczyński, J. (2018) · Structural Chemistry · doi:10.1007/s11224-018-1100-x · Cited by 7
Proteome Analysis of a M. avium Mutant Exposes a Novel Role of the Bifunctional Protein LysX in the Regulation of Metabolic Activity
Kirubakar, G., Murugaiyan, J., Schaudinn, C., Dematheis, F., Holland, G., Eravci, M., Weise, C., Roesler, U. H., & Lewin, A. (2018) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiy100 · Cited by 7
Growth and protease secretion of Scedosporium aurantiacum under conditions of hypoxia
Han, Z., Kautto, L., Meyer, W., Chen, S. C. ‐., & Nevalainen, H. K. M. (2018) · Microbiological Research · doi:10.1016/j.micres.2018.08.003 · Cited by 7
High-yield production of major T-cell ESAT6-CFP10 fusion antigen of M. tuberculosis complex employing codon-optimized synthetic gene
Gutiérrez‐Ortega, A., Moreno, D. A. N., Ferrari, S. A., Espinosa‐Andrews, H., Ortíz, E. P., Milián-Suazo, F., & Álvarez, Á. H. (2021) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2020.12.179 · Cited by 7
Tuberculous Lymphadenitis and Parotitis
Cataño, J. C., & Robledo, J. (2017) · ASM Press eBooks · doi:10.1128/9781555819866.ch21 · Cited by 7
Integration of cytopathology with molecular tests to improve the lab diagnosis for TBLN suspected patients
Atnafu, A., Desta, K., Girma, S., Hailu, D., Assefa, G., Araya, S., Bekele, D., Wassie, L., & Bobosha, K. (2022) · PLoS ONE · doi:10.1371/journal.pone.0265499 · Cited by 6
Variants of human DECTIN-1 rs16910526 are linked to differential reactive oxygen species production and susceptibility to tuberculosis
Cufré, M., Pastorini, M., Martín, I., Failde, R., Palmero, D., & Alemán, M. (2024) · Journal of Biomedical Science · doi:10.1186/s12929-024-01067-w · Cited by 6
Insights into Natural Products from Marine-Derived Fungi with Antimycobacterial Properties: Opportunities and Challenges
Azhari, M., Merliani, N., Singgih, M., Arai, M., & Julianti, E. (2025) · Marine Drugs · doi:10.3390/md23070279 · Cited by 7
Coupling 6-chloro-3-methyluracil with copper: structural features, theoretical analysis, and biofunctional properties
Kumar, B., Das, T. K., Das, S., Maniukiewicz, W., Nesterov, D. S., Kirillov, A. M., & Das, S. (2021) · Dalton Transactions · doi:10.1039/d1dt02018h · Cited by 6
Prevalence of Hepatitis B Virus, Human Immune Deficiency Virus and Associated Risk Factors Among Individuals with Presumptive Pulmonary Tuberculosis Attending at Saint Peter’s Specialized Hospital, Addis Ababa, Ethiopia
Gebrehiwet, K., Biranu, E., Nigatu, W., Gebreegziabher, A., & Desta, K. (2023) · Infection and Drug Resistance · doi:10.2147/idr.s410260 · Cited by 6
Role of Diagnostic procedures in managing human Bacterial infections: A comprehensive overview
Bhowmik, A. (2023) · Archives of Hematology Case Reports and Reviews · doi:10.17352/ahcrr.000043 · Cited by 6
Nanotechnological innovations in paediatric tuberculosis management: current trends and future prospects
Ajayi, T. O., Poka, M., & Witika, B. A. (2024) · Frontiers in Drug Delivery · doi:10.3389/fddev.2023.1295815 · Cited by 6
Nonribosomal Peptide Synthetases
Montavon, T. J., & Bruner, S. D. (2010) · Elsevier eBooks · doi:10.1016/b978-008045382-8.00680-8 · Cited by 6
Models for Antitubercular Activity of 5'-O-[(N-Acyl)sulfamoyl]adenosines
Goyal, R. K. (2010) · Scientia Pharmaceutica · doi:10.3797/scipharm.1006-03 · Cited by 6
Comparative Proteome Analysis of Mycobacterium Tuberculosis Strains - H37Ra, H37Rv, CCDC5180, and CAS/NITR204: A Step Forward to Identify Novel Drug Targets
Gupta, S. R. R., Gupta, E., Ohri, A., Shrivastava, S. K., Kachhwaha, S., Sharma, V., Mishra, R. K., & Niraj, R. R. K. (2020) · Letters in Drug Design & Discovery · doi:10.2174/1570180817999200531165148 · Cited by 6
Proteomic analysis reveals critical molecular mechanisms involved in the macrophage anti-spinal tuberculosis process
Xu, G., Xue, J., Jiang, J., Liang, T., Yao, Y., Liao, S., Chen, T., Li, H., Liu, C., & Zhan, X. (2020) · Tuberculosis · doi:10.1016/j.tube.2020.102039 · Cited by 6
Challenges and Opportunities of Nanotechnological based Approach for the Treatment of Tuberculosis
Rath, G., Pradhan, D., Ghosh, G., & Goyal, A. K. (2021) · Current Pharmaceutical Design · doi:10.2174/1381612827666210226121359 · Cited by 6
Determination of variable region sequences from hybridoma immunoglobulins that target Mycobacterium tuberculosis virulence factors
Foreman, H.-C. C., Frank, A. M., & Stedman, T. T. (2021) · PLoS ONE · doi:10.1371/journal.pone.0256079 · Cited by 6
Comparison of Macrophage Immune Responses and Metabolic Reprogramming in Smooth and Rough Variant Infections of Mycobacterium mucogenicum
Kang, M., Kim, H. W., Yu, A.-R., Yang, J. S., Lee, S. H., Lee, J., Yoon, H. S., Lee, B. S., Park, H., Lee, S. K., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23052488 · Cited by 6
Rv3737 is required for Mycobacterium tuberculosis growth in vitro and in vivo and correlates with bacterial load and disease severity in human tuberculosis
Li, Q., Peng, Z., Fu, X., Wang, H., Zhao, Z., Pang, Y., & Chen, L. (2022) · BMC Infectious Diseases · doi:10.1186/s12879-021-06967-y · Cited by 6
Efficacy of Dry Heat Treatment against Clostridioides difficile Spores and Mycobacterium tuberculosis on Filtering Facepiece Respirators
Soni, A., Parlane, N. A., Khan, F., Derraik, J. G. B., Wild, C. E. K., Anderson, Y. C., & Brightwell, G. (2022) · Pathogens · doi:10.3390/pathogens11080871 · Cited by 6
Design, Synthesis, and Biological Evaluation of Quinoxaline Bearing Tetrahydropyridine Derivatives as Anticancer, Antioxidant, and Anti- Tubercular Agents
Ramana, M. M. V., Pavale, G., Acharya, P., & Korgavkar, N. (2022) · Current Computer - Aided Drug Design · doi:10.2174/1573409918666220804142753 · Cited by 6
Synthesis and Biological Activities of Some 1,2,4-Triazole Derivatives: A Review
Ameen, D. S. M., Al-Ameedee, M. D., & Khan, A. K. (2022) · Al Mustansiriyah Journal of Pharmaceutical Sciences · doi:10.32947/ajps.v22i3.890 · Cited by 6
Novel starting points for fragment-based drug design against mycobacterial thioredoxin reductase identified using crystallographic fragment screening
Füsser, F. T., Wollenhaupt, J., Weiss, M. S., Kümmel, D., & Koch, O. (2023) · Acta Crystallographica Section D Structural Biology · doi:10.1107/s2059798323005223 · Cited by 6
Sulphides from garlic essential oil dose-dependently change the distribution of glycerophospholipids and induce N6-tuberculosinyladenosine formation in mycobacterial cells
Sawicki, R., Widelski, J., Truszkiewicz, W., Kawka, S., Kai, G., & Sieniawska, E. (2023) · Scientific Reports · doi:10.1038/s41598-023-47750-0 · Cited by 6
Recent advances in tuberculosis: A comprehensive review of emerging trends in pathogenesis, diagnostics, treatment, and prevention
Al-Karawi, A. S., Kadhim, A. A., & Kadum, M. M. (2024) · International Journal of Clinical Biochemistry and Research · doi:10.18231/j.ijcbr.2023.048 · Cited by 6
4-(Benzyloxy)phenol-induced p53 exhibits antimycobacterial response triggering phagosome-lysosome fusion through ROS-dependent intracellular Ca2+ pathway in THP-1 cells
Naik, L., Patel, S., Kumar, A., Ghosh, A., Mishra, A., Das, M., Nayak, D. K., Saha, S., Mishra, A., Singh, R., et al. (2024) · Microbiological Research · doi:10.1016/j.micres.2024.127664 · Cited by 6
Can mycobacterial katG genetic changes in isoniazid-resistant tuberculosis influence human disease features?
Escalante, P., McKean‐Cowdin, R., Ramaswamy, S. V., Williams‐Bouyer, N., Teeter, L. D., Jones, B. E., & Graviss, E. A. (2013) · The International Journal of Tuberculosis and Lung Disease · doi:10.5588/ijtld.12.0380 · Cited by 6
Phospholipase C in Beijing strains of Mycobacterium tuberculosis.
Goudarzi, H., Es, M., Farnia, P., Sherafat, S. J., Esfahani, M., & Faramarzi, N. (2010) · Europe PMC (PubMed Central) · Cited by 6
Mycobacterial Porins
Niederweis, M. (2014) · ASM Press eBooks · doi:10.1128/9781555815783.ch9 · Cited by 6
The VapBC1 toxin–antitoxin complex fromMycobacterium tuberculosis: purification, crystallization and X-ray diffraction analysis
Lu, Z., Wang, H., Zhang, A., & Tan, Y. (2016) · Acta Crystallographica Section F Structural Biology Communications · doi:10.1107/s2053230x16007603 · Cited by 6
XPERT MYCOBACTERIUM TUBERCULOSIS/RIFAMPICIN ASSAY: A BOON IN TUBERCULOSIS DIAGNOSTICS
Bhat, S., Ramamurthy, K., Shenoy, S. M., & Rangnekar, A. (2016) · Asian Journal of Pharmaceutical and Clinical Research · doi:10.22159/ajpcr.2016.v9i5.13315 · Cited by 6
Fluorescence Imaging of Mycobacterial Infection in Live Mice Using Fluorescent Protein-Expressing Strains
Kong, Y., & Cirillo, J. D. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-7860-1_6 · Cited by 6
Targeting wild‐type and drug‐resistant mycobacteria in infected macrophages using drug‐coated nanoparticles
Cotta, K. B., Padwal, P., Agarwal, S., Bandyopadhyaya, R., & Mehra, S. (2018) · Journal of Chemical Technology & Biotechnology · doi:10.1002/jctb.5822 · Cited by 6
Direct-from-sputum rapid phenotypic drug susceptibility test for mycobacteria
Butler, T. E., Lee, A. J., Yang, Y., Newton, M. D., Kargupta, R., Puttaswamy, S., & Sengupta, S. (2020) · PLoS ONE · doi:10.1371/journal.pone.0238298 · Cited by 6
Vaccine delivery systems against tuberculosis
Ojha, R., Pandey, R. K., & Prajapati, V. K. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819811-7.00005-9 · Cited by 6
A protein fragment of Rv3194c located on mycobacterial cell surface efficiently prevents adhesion of recombinant Mycobacterium smegmatis, and promises a new anti-adhesive drug
Zhao, D., Lin, D., & Xu, C. (2020) · Microbial Pathogenesis · doi:10.1016/j.micpath.2020.104498 · Cited by 6
A Long-Acting Thermoresponsive Injectable Formulation of Tin Protoporphyrin Sustains Antitubercular Efficacy in a Murine Infection Model
Adeleke, O. A., Fisher, L., Moore, I. N., Nardone, G. A., & Sher, A. (2020) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.0c00185 · Cited by 6
Who Has Mycobacterial Disease? A Cross Sectional Study in Agropastoral Communities in Tanzania
Kilale, A. M., Ngadaya, E. S., Muhumuza, J., Kagaruki, G. B., Lema, Y. L., Ngowi, B. J., Mfinanga, S., & Hinderaker, S. G. (2016) · PLoS ONE · doi:10.1371/journal.pone.0153711 · Cited by 6
The Future of Vaccines for Tuberculosis
Stockdale, L. K., & Fletcher, H. A. (2019) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2019.07.009 · Cited by 6
Mycobacterium tuberculosis concealed by enterococcal sacroiliitis
Chandradevan, R., Takeda, H., Lim, T., & Patel, N. (2020) · IDCases · doi:10.1016/j.idcr.2020.e00858 · Cited by 6
Molecular modeling and in silico characterization of mycobacterial Rv3101c and Rv3102c proteins: prerequisite molecular target in cell division
Beg, M. A., & Athar, F. (2020) · Pharmacy & Pharmacology International Journal · doi:10.15406/ppij.2020.08.00300 · Cited by 6
In-silico development of a novel TLR2-mediating multi-epitope vaccine against Mycobacterium tuberculosis
Singh, S., Verma, P., Gaur, M., Bhati, L., Madan, R., Sharma, P. P., Rawat, A., Rathi, B., & Singh, M. (2025) · In Silico Pharmacology · doi:10.1007/s40203-025-00322-8 · Cited by 5
Fog caused distinct diversity of airborne bacterial communities enriched with pathogens over central Indo-Gangetic plain in India
Saikh, S. R., Mushtaque, M. A., Pramanick, A., Prasad, J. K., Roy, D., Saha, S., & Das, S. K. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e26370 · Cited by 5
Molecular dynamics simulations, essential dynamics and MMPBSA to evaluate natural compounds as potential inhibitors for AccD6, a key drug target in the fatty acid biosynthesis pathway in Mycobacterium tuberculosis
Singha, C. J., & Krishna, R. (2024) · Journal of Molecular Graphics and Modelling · doi:10.1016/j.jmgm.2024.108898 · Cited by 5
The prominent alteration in transcriptome and metabolome of Mycobacterium bovis BCG str. Tokyo 172 induced by vitamin B1
Song, N., Li, Z., Cui, Z., Chen, L., Cui, Y., Dang, G., Li, Z., Li, H., & Liu, S. (2019) · BMC Microbiology · doi:10.1186/s12866-019-1492-9 · Cited by 5
Identification of Mycobacterium tuberculosis isolated from culture-negative pulmonary and extra-pulmonary samples in cases of suspected tuberculosis
Harirzadeh, S., Kazemi, M. J., & Babakhani, S. (2019) · Europe PMC (PubMed Central) · doi:10.3205/dgkh000325 · Cited by 5
Classification and functional analyses of putative virulence factors of Mycobacterium tuberculosis: A combined sequence and structure based study
Shahbaaz, M., Potemkin, V., Bisetty, K., Hassan, M. I., & Hussien, M. A. (2020) · Computational Biology and Chemistry · doi:10.1016/j.compbiolchem.2020.107270 · Cited by 5
Structural analyses and classification of novel isoniazid resistance coupled mutational landscapes inMycobacterium tuberculosis: a combined molecular docking and MD simulation study
Shahbaaz, M., Qari, S. H., Abdellattif, M. H., & Hussien, M. A. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1861986 · Cited by 5
Identification of novel scaffolds to inhibit Mycobacterium tuberculosis PimA protein—A computational approach
Damera, T., Kondaparthi, V., Bingi, M., Mustyala, K. K., & Malkhed, V. (2023) · Journal of Cellular Biochemistry · doi:10.1002/jcb.30412 · Cited by 5
Mycobacteriaceae Phenome Atlas (MPA): A Standardized Atlas for the Mycobacteriaceae Phenome Based on Heterogeneous Sources
Liu, W., Cen, H., Wu, Z., Zhou, H., Chen, S., Yang, X., Zhao, G., & Zhang, G. (2023) · Phenomics · doi:10.1007/s43657-023-00101-5 · Cited by 5
Impact of anti-tuberculosis treatment on hematological parameters in newly diagnosed tuberculosis patients at Jimma town: a longitudinal prospective study
Reta, B., Mohammed, A. E., Kiya, G. T., Adissu, W., & Shenkute, T. Y. (2023) · Annals of Medicine and Surgery · doi:10.1097/ms9.0000000000001084 · Cited by 5
Metabolic engineering of Micromonospora for exploring useful natural products and phytobiotic interaction
Gu, B., Lee, J., Kim, D. G., Cha, Y.-J., & Oh, M. (2025) · Metabolic Engineering · doi:10.1016/j.ymben.2025.07.005 · Cited by 5
Gruźlica narządów głowy i szyi – wciąż aktualny problem w praktyce laryngologicznej
Markowski, J., Witkowska, M., Gierek, T., Pasternak, K., Ciupińska-Kajor, M., Kajor, M., Paluch, J., & Smółka, K. (2011) · Otolaryngologia Polska · doi:10.1016/s0030-6657(11)70689-8 · Cited by 5
Characterization of MymA protein as a flavin‐containing monooxygenase and as a target of isoniazid
Saraav, I., Pandey, K., Misra, R., Singh, S., Sharma, M., & Sharma, S. (2016) · Chemical Biology & Drug Design · doi:10.1111/cbdd.12840 · Cited by 5
Theoretical insights on the binding of isoniazid to the active site residues of Mycobacterium tuberculosis catalase-peroxidase
Reyes, Y. I. A., Janairo, G. C., & Franco, F. C. (2018) · Tuberculosis · doi:10.1016/j.tube.2018.11.005 · Cited by 5
The PE and PPE Family Proteins of Mycobacterium tuberculosis: What they Are Up To?
Pal, R. K., Nazar, F., & Mukhopadhyay, S. (2019) · Springer eBooks · doi:10.1007/978-981-32-9413-4_8 · Cited by 5
Progressive Insights into the Pharmacological Importance of Isoquinoline Derivatives in Modern Therapeutics
Danao, K. R., Malghade, P. M., Mahapatra, D. K., Motiwala, M. N., & Mahajan, U. (2021) · International Journal of Current Research and Review · doi:10.31782/ijcrr.2021.13421 · Cited by 5
Take my breath away: studying pathogen invasion of the human lung using primary tissue models
Dragan, A. L., & Voth, D. E. (2021) · Pathogens and Disease · doi:10.1093/femspd/ftab016 · Cited by 5
Bacteriophages in Therapeutics
Bhardwaj, S. B. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.90988 · Cited by 5
Review of Pediatric Tuberculosis in the Aftermath of COVID-19
Rangchaikul, P., Ahn, P., Nguyen, M., Zhong, V., & Venketaraman, V. (2022) · Clinics and Practice · doi:10.3390/clinpract12050077 · Cited by 6
Prevalence of latent tuberculosis infection in the household contacts of pulmonary tuberculosis, time to treat
Sangma, V. S. C., Jaggi, S., Saini, V., Aggarwal, D., Kumar, P. M., & Chander, J. (2023) · Monaldi Archives for Chest Disease · doi:10.4081/monaldi.2023.2563 · Cited by 5
Siderophores: A Novel Approach to Fight Antimicrobial Resistance
Ribeiro, M., & Simões, M. V. (2019) · Environmental chemistry for a sustainable world · doi:10.1007/978-3-030-04675-0_5 · Cited by 5
Design of Novel Antimycobacterial Molecule Targeting Shikimate Pathway of Mycobacterium tuberculosis
Sivaranjani, P., Vankadoth, U. N., Nalamolu, R. M., Kumar, K. S., Chiranjeevi, P., Alexander, S. P., & Umamaheswari, A. (2019) · Indian Journal of Pharmaceutical Sciences · doi:10.36468/pharmaceutical-sciences.528 · Cited by 5
Interactions of Mycobacterium tuberculosis with Human Mesenchymal Stem Cells
Khan, A., & Jagannath, C. (2019) · Springer eBooks · doi:10.1007/978-3-030-25381-3_5 · Cited by 5
Mining the Mycobacterium tuberculosis proteome for identification of potential T-cell epitope based vaccine candidates
Madan, R., Pandit, K., Bhati, L., Kumar, H., Kumari, N., & Singh, S. (2021) · Microbial Pathogenesis · doi:10.1016/j.micpath.2021.104996 · Cited by 5

Authors: Smith, I.
Affiliations: International Center for Public Health (US)
Corresponding author: Smith, Issar
Venue: Clinical Microbiology Reviews
Publisher: American Society for Microbiology
Published: 2003-07
Volume: 16
Issue: 3
Pages: 463-496
ISSN: 0893-8512 (ISSN-L)
1098-6618
DOI: 10.1128/cmr.16.3.463-496.2003
PMC: PMC164219
OpenAlex: W2157638040
Cited by: 1,154
References: 322
Citations by year: 2026: 29 · 2025: 56 · 2024: 57 · 2023: 87 · 2022: 87 · 2021: 87 · 2020: 84 · 2019: 76 · 2018: 73 · 2017: 54 · 2016: 57 · 2015: 54 · 2014: 46 · 2013: 54 · 2012: 33
FWCI: 3.73
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: journals.asm.org/non-commercial-tdm-license (tdm)
Locations: Clinical Microbiology Reviews (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Funders: National Institutes of Health
National Heart, Lung, and Blood Institute (R01 HL 68513, R01HL064544, R01 HL 64544, R01HL068513)
National Institute of Allergy and Infectious Diseases (R01 AI 48856, R01AI048856)
Topics: Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
Health Sciences › Medicine › Infectious Diseases › Infectious Diseases and Tuberculosis
Health Sciences › Medicine › Epidemiology › Mycobacterium research and diagnosis
Keywords: Mycobacterium tuberculosis, tuberculosis pathogenesis, bacterial virulence factors, host immune response, pulmonary tuberculosis, transmissibility, host genetics, host nutritional status, tuberculosis vaccine, tuberculosis drug targets, tuberculosis diagnosis
MeSH terms: Animals, Antitubercular Agents, Disease Models, Animal, Humans, Macrophages, Mycobacterium tuberculosis, Transcription, Genetic, Tuberculosis, Virulence, Genome, Bacterial, Proteomics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Mycobacterium tuberculosis Pathogenesis and Molecular Determinants of Virulence

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks